ReviewBiomolecules2026
Enhancer Trajectories in Lineage Commitment: Regulatory Logic of States and Cooperation.
Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When Fertilization Is Not Enough: Maternal-Zygotic Transition as a Determinant of Embryo Competence in IVF.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cell fate determination depends on precise and timely control of gene expression programs governed by enhancers, which act as central regulatory elements within chromatin landscapes. Recent studies reveal that enhancers occupy distinct functional states, including poised, primed, and active configurations, and that these states dynamically transition during lineage specification. These transitions, in turn, coordinate chromatin accessibility and transcriptional competence, establishing when and how developmental genes become activated. Beyond individual enhancers, some fate-defining loci employ modular and shadow enhancer architectures that cooperatively regulate transcriptional dose, maintain threshold stability, and buffer developmental programs against stochastic and environmental variation. Comparative analyses across neural, cardiac, and hematopoietic systems illustrate how these enhancer modules are selectively deployed to achieve lineage-specific precision and robustness. Furthermore, enhancer timing, persistence, and quantitative thresholds collectively encode developmental tempo and stability, ensuring faithful progression of cell fate transitions. By considering molecular state transitions together with cooperative enhancer architecture, this review organizes current views on how enhancers may help translate transient cues into stable lineage outcomes, thereby linking chromatin dynamics to developmental precision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.